Global Non-alcoholic Steatohepatitis Market Survey and Trend Research 2018

September 2018 | 74 pages | ID: GABD0FA8C81EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Vivus, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead, Immuron, Interceptpharma, Raptor Pharmaceutical, Shire, Tobira Therapeutics, Verva, Viking Therapeutics etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Non-alcoholic Steatohepatitis Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NON-ALCOHOLIC STEATOHEPATITIS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 AstraZeneca (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Arena Pharmaceuticals (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 GSK (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Novo Nordisk (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Vivus (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Vivus (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Arisaph Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Cempra Pharmaceuticals (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Galectin Therapeutics (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Galmed Pharmaceuticals (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Genfit (Company Overview, Sales Data etc.)
4.12 Gilead (Company Overview, Sales Data etc.)
4.13 Immuron (Company Overview, Sales Data etc.)
4.14 Interceptpharma (Company Overview, Sales Data etc.)
4.15 Raptor Pharmaceutical (Company Overview, Sales Data etc.)
4.16 Shire (Company Overview, Sales Data etc.)
4.17 Tobira Therapeutics (Company Overview, Sales Data etc.)
4.18 Verva (Company Overview, Sales Data etc.)
4.19 Viking Therapeutics (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Non-alcoholic Steatohepatitis Market 2012-2017, by Type, in USD Million
Table Global Non-alcoholic Steatohepatitis Market Forecast 2018-2023, by Type, in USD Million
Table AstraZeneca Overview List
Table Non-alcoholic Steatohepatitis Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)
Table Arena Pharmaceuticals Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Arena Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table GSK Overview List
Table Non-alcoholic Steatohepatitis Business Operation of GSK (Sales Revenue, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Novo Nordisk (Sales Revenue, Cost, Gross Margin)
Table Vivus Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Vivus (Sales Revenue, Cost, Gross Margin)
Table Vivus Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Vivus (Sales Revenue, Cost, Gross Margin)
Table Arisaph Pharmaceuticals Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Arisaph Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Cempra Pharmaceuticals Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Cempra Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Galectin Therapeutics Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Galectin Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Galmed Pharmaceuticals Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Galmed Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Genfit Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Genfit (Sales Revenue, Cost, Gross Margin)
Table Gilead Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Gilead (Sales Revenue, Cost, Gross Margin)
Table Immuron Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Immuron (Sales Revenue, Cost, Gross Margin)
Table Interceptpharma Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Interceptpharma (Sales Revenue, Cost, Gross Margin)
Table Raptor Pharmaceutical Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Raptor Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Shire Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
Table Tobira Therapeutics Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Tobira Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Verva Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Verva (Sales Revenue, Cost, Gross Margin)
Table Viking Therapeutics Overview List
Table Non-alcoholic Steatohepatitis Business Operation of Viking Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Global Non-alcoholic Steatohepatitis Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Non-alcoholic Steatohepatitis Sales Revenue Share, by Companies, in USD Million
Table Non-alcoholic Steatohepatitis Demand 2012-2017, by Application, in USD Million
Table Non-alcoholic Steatohepatitis Demand Forecast 2018-2023, by Application, in USD Million
Table Global Non-alcoholic Steatohepatitis Market 2012-2017, by Region, in USD Million
Table Non-alcoholic Steatohepatitis Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Non-alcoholic Steatohepatitis Industry Chain Structure
Figure Global Non-alcoholic Steatohepatitis Market Growth 2012-2017, by Type, in USD Million
Figure Global Non-alcoholic Steatohepatitis Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region